Rhabdomyolysis associated with fibrate therapy: review of 76 published cases and a new case report
作者： Jianyong Wu , Yan Song , Heng Li , Jianghua Chen , None
DOI: 10.1007/S00228-009-0723-7
关键词: Fibrate 、 Rhabdomyolysis 、 Drug interaction 、 Intensive care medicine 、 MEDLINE 、 Pharmacology toxicology 、 Surgery 、 Fenofibrate 、 Potential risk 、 Dyslipidemia 、 Medicine
摘要: Purpose Fibrates are used to manage mixed dyslipidemia. However, these drugs have the potential risk of inducing rhabdomyolysis. This paper gives an overview literature on rhabdomyolysis associated with fibrate therapy.
springer.com
sci-hub.se 参考文章(66)
Roberto Lufschanowski, D. Richard Leachman, Theodore K. Lau, Severe Rhabdomyolysis Associated with the Cerivastatin-Gemfibrozil Combination Therapy: Report of a Case Texas Heart Institute Journal. ,vol. 28, pp. 142- 145 ,(2001)
B Koçak, S Korkmaz, O Ozdemir, Y Uzun, M Boran, V Gökçe, A case with severe rhabdomyolysis and renal failure associated with cerivastatin-gemfibrozil combination therapy--a case report. Angiology. ,vol. 51, pp. 695- 697 ,(2000)
S Ramachandran, PD Giles, A Hartland, Acute renal failure due to rhabdomyolysis in presence of concurrent ciprofibrate and ibuprofen treatment. BMJ. ,vol. 314, pp. 1593- 1593 ,(1997) , 10.1136/BMJ.314.7094.1593A
Severe rhabdomyolysis induced by a retard formulation of bezafibrate in a CAPD patient. Nephron. ,vol. 73, pp. 736- 736 ,(1996) , 10.1159/000189184
ALEXANDER TAL, MAHALINGAM RAJESHAWARI, WILLIAM ISLEY, Rhabdomyolysis associated with simvastatin-gemfibrozil therapy. Southern Medical Journal. ,vol. 90, pp. 546- 547 ,(1997) , 10.1097/00007611-199705000-00018
Patrick E. McBride, Amy Haavisto Kind, Laura J. Zakowski, Rhabdomyolysis from the combination of a statin and gemfibrozil: an uncommon but serious adverse reaction. WMJ : official publication of the State Medical Society of Wisconsin. ,vol. 101, pp. 53- 56 ,(2002)
Robert H. Knopp, Drug treatment of lipid disorders The New England Journal of Medicine. ,vol. 341, pp. 498- 511 ,(1999) , 10.1056/NEJM199908123410707
Hamish Simpson, Rhabdomyolysis associated with cerivastatin plus gemfibrozil combined regimen. British Journal of General Practice. ,vol. 52, pp. 235- 236 ,(2002)
Alan N Baer, Robert L Wortmann, Myotoxicity associated with lipid-lowering drugs. Current Opinion in Rheumatology. ,vol. 19, pp. 67- 73 ,(2007) , 10.1097/BOR.0B013E328010C559
Robert H Eckel, KGMM Alberti, Scott M Grundy, Paul Z Zimmet, The metabolic syndrome The Lancet. ,vol. 365, pp. 1415- 1428 ,(2005) , 10.1016/S0140-6736(09)61794-3